While FDA has authorized two COVID-19 antiviral medications—Paxlovid from Pfizer and molnupiravir from Merck, Americans may not have the easiest time accessing these medications, which are aimed at preventing hospitalizations and deaths in high-risk patients.

Loren Bonner

Whether it’s to help a parent looking for a product for their teething infant or a college-aged student interested in options to manage cold sores, we have pharmacologic and nonpharmacologic options to help patients with oral disorders.

Daniel L. Krinsky, BS, MS, RPh, FAPhA

Although supplement sales have skyrocketed since the beginning of the pandemic, there is no scientific evidence that immune-boosting supplements can cure or prevent COVID-19 infection.

Johanna Taylor Katroscik, PharmD

Updates from FDA

APhA Staff

Results of a September 2021 study by Howard and colleagues published in the Journal of the American College of Cardiology show that, in patients with a history of stopping statin therapy due to intolerable adverse effects, a similar amount of adverse effects were observed whether patients were rechallenged with a statin or were taking a placebo.

Maria G. Tanzi, PharmD